Toyama Chemical Company Chemical Submits IND For Its Anti-Influenza Compound ‘T-705'

TOKYO--(BUSINESS WIRE)--Toyama Chemical Co., Ltd., (TOKYO:4518) (Headquarters: Tokyo, Japan; President: Katsuhiko Nakano) submitted an IND (Investigational New Drug) application to the United States FDA (Food and Drug Administration) on January 17, 2007 for its anti-influenza virus compound “T-705.”